STOCK TITAN
  1. Home
  2. Sec-filings
  3. AHCO
  4. [Form 3] AdaptHealth Corp. Initial Statement of Beneficial Ownership

AdaptHealth Executive Takes Stake: McFadden Granted 54K Restricted Shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

AdaptHealth Corp (AHCO) filed a Form 3 Initial Statement of Beneficial Ownership for Daniel Edward McFadden, who has been appointed as the company's Chief Business Systems Officer. The filing, dated June 28, 2025, discloses McFadden's initial beneficial ownership position in the company.

Key ownership details:

  • McFadden beneficially owns 53,958 shares of common stock in the form of restricted stock units (RSUs)
  • The ownership is held directly (D)
  • The RSUs will be settled in common stock upon vesting

The filing was executed by Richard Rew as attorney-in-fact for Daniel McFadden on June 26, 2025. This Form 3 filing is required under Section 16(a) of the Securities Exchange Act of 1934 for new officers, directors, or beneficial owners of more than 10% of a company's securities.

Positive

  • None.

Negative

  • None.
Insider McFadden Daniel Edward
Role Chief Business Systems Officer
Type Security Shares Price Value
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 53,958 shares (Direct)
Footnotes (1)
  1. F1. These shares represent restricted stock units and will be settled in common stock upon vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding Insider Trading Forms →

FAQ

Who is Daniel McFadden at AHCO and what position was he appointed to?
Daniel McFadden was appointed as Chief Business Systems Officer at AdaptHealth Corp (AHCO). This is disclosed in his Form 3 filing dated June 28, 2025, which reports his initial statement of beneficial ownership as an officer of the company.

How many shares of AHCO does Daniel McFadden own upon appointment?
According to the Form 3 filing, Daniel McFadden beneficially owns 53,958 shares of AHCO common stock in the form of restricted stock units (RSUs) that will be settled in common stock upon vesting. These shares are held directly (ownership form: D).

Does AHCO's new Chief Business Systems Officer own any derivative securities?
No, according to Table II of the Form 3 filing, Daniel McFadden does not own any derivative securities such as stock options, puts, calls, warrants, or convertible securities in AHCO at the time of his appointment.

When did Daniel McFadden's appointment at AHCO become effective?
According to the Form 3 filing, the date of event requiring the statement was June 9, 2025, which indicates this was the effective date of Daniel McFadden's appointment as Chief Business Systems Officer at AdaptHealth Corp.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
McFadden Daniel Edward
(Last) (First) (Middle)
C/O ADAPTHEALTH LLC
555 EAST NORTH LANE, SUITE 5075
(Street)
CONSHOHOCKEN PA 19428
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/09/2025 		3. Issuer Name and Ticker or Trading Symbol
AdaptHealth Corp. [ AHCO ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Business Systems Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 53,958(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares represent restricted stock units and will be settled in common stock upon vesting.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Richard Rew as attorney in fact for Daniel McFadden 06/26/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR